Nimodipine is a dihydropyridine calcium channel antagonist that blocks the flux of
extracellular calcium through L-type, voltage-gated calcium channels. While nimodipine is …

Subarachnoid hemorrhage (SAH) is a devastating stroke subtype with a high rate of
mortality and morbidity. The poor clinical outcome can be attributed to the biphasic course of …

Objective Delayed cerebral ischemia (DCI) is strongly associated with poor outcome after
subarachnoid hemorrhage (SAH). Cerebral vasospasm is a major contributor to DCI and …

Background Early computed tomography perfusion (CTP) is frequently used to predict
delayed cerebral ischemia following aneurysmatic subarachnoid hemorrhage (aSAH) …

Objectives: Cerebral vasospasm is one of the leading causes of morbi-mortality following
aneurysmal subarachnoid hemorrhage. The aim of this article is to discuss the current status …

Objectives To examine the clinical outcome of aneurysmal subarachnoid haemorrhage
(aSAH) patients exposed to cerebral vasospasm (CVS)-targeted treatments in a meta …

Delayed ischemic neurologic deficit (DIND) is a serious and poorly understood complication
of aneurysmal subarachnoid hemorrhage. Although advances in treatment have improved …

Background: The implementation of rescue efforts for delayed cerebral ischemia after
aneurysmal subarachnoid hemorrhage remains largely empirical for a lack of supporting …

Background and purpose Delayed cerebral ischemia (DCI) is a complication of aneurysmal
subarachnoid hemorrhage (SAH). Arterial cerebral vasospasm (CVS) is discussed as the …

Background We demonstrated experimentally that inhaled nitric oxide (iNO) dilates
hypoperfused arterioles, increases tissue perfusion, and improves neurological outcome …